Unknown

Dataset Information

0

18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.


ABSTRACT:

Objective

The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for the detection of residual disease after (chemo)radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic value of the FDG-PET/CT findings.

Methods

Patients with HNSCC who underwent FDG-PET/CT after (chemo)radiotherapy were studied retrospectively.

Results

104 FDG-PET/CT-scans were performed at a median of 13.2 weeks post-treatment (5.4-19.0 weeks). The diagnostic performance was time dependent with decreasing sensitivity and slightly increasing specificity over time. Sensitivity, specificity, PPV and NPV at 9 months after imaging were 91%, 87%, 77% and 95%, respectively. In a logistic regression model, the odds of a correct FDG-PET/CT increased with 33% every additional week after end of therapy (p = 0.01) and accuracy plateaued after 11 weeks (97%; p<0.001). A complete response on FDG-PET/CT was associated with an overall survival benefit (50.7 versus 10.3 months; p<0.001). Residual disease on FDG-PET/CT increased the risk of death 8-fold (p<0.001).

Conclusion

FDG-PET/CT is able to detect residual disease after (chemo)radiotherapy, with an optimal time point for scanning between 11-12 weeks after therapy. However, a reevaluation is probably necessary 10-12 months after the FDG-PET/CT to detect late recurrences. In addition, FDG-PET/CT can guide decisions about neck dissection and identifies patients with poor prognosis.

SUBMITTER: Helsen N 

PROVIDER: S-EPMC5542639 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.

Helsen Nils N   Roothans Dessie D   Van Den Heuvel Bert B   Van den Wyngaert Tim T   Van den Weyngaert Danielle D   Carp Laurens L   Stroobants Sigrid S  

PloS one 20170803 8


<h4>Objective</h4>The aim of this study is to evaluate the diagnostic performance of FDG-PET/CT for the detection of residual disease after (chemo)radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC) and to evaluate the prognostic value of the FDG-PET/CT findings.<h4>Methods</h4>Patients with HNSCC who underwent FDG-PET/CT after (chemo)radiotherapy were studied retrospectively.<h4>Results</h4>104 FDG-PET/CT-scans were performed at a median of 13.2 weeks post-treatment (5.4  ...[more]

Similar Datasets

| S-EPMC8307331 | biostudies-literature
| S-EPMC8342266 | biostudies-literature
| S-EPMC6362604 | biostudies-literature
| S-EPMC7205972 | biostudies-literature
| S-EPMC7952491 | biostudies-literature
| S-EPMC5664237 | biostudies-literature
| S-EPMC6306774 | biostudies-literature
| S-EPMC5710655 | biostudies-literature
| S-EPMC7830971 | biostudies-literature
| S-EPMC9156589 | biostudies-literature